Form 4: Agios Pharmaceuticals Officer Sells Shares
SEC Form 4 Filing
Theodore James Jr. Washburn, Principal Accounting Officer of Agios Pharmaceuticals, sold 1,913 shares of common stock at $31.75 per share on March 5, 2024.
Summary
- On March 5, 2024, Theodore James Jr. Washburn, the Principal Accounting Officer of Agios Pharmaceuticals, sold 1,913 shares of the company's common stock.
- The sale price was $31.75 per share.
- Following the transaction, Washburn directly owns 2,886 shares of Agios Pharmaceuticals.
Sentiment
Score: 5
Explanation: This is a neutral event. An officer sold shares, which could be for a variety of personal financial reasons and doesn't necessarily reflect a negative outlook on the company.
Industry Context
Form 4 filings are a routine part of the US stock market and are required by the SEC to ensure transparency of trading by corporate insiders. This filing indicates a sale of shares by an officer of Agios Pharmaceuticals.
Stakeholder Impact
- The sale of shares by a company officer could be perceived negatively by some shareholders, although it may not have a significant impact.
Key Dates
| Date | Description |
|---|---|
| 03/05/2024 | Date of the stock sale transaction. |
| 03/07/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.